Pesquisas alternativas:
devel » level (Expandir a Pesquisa), devem (Expandir a Pesquisa)
ther » them (Expandir a Pesquisa)
A mostrar 1 - 20 resultados de 1,637 para a pesquisa '((((((drug de) OR (drug co))) OR (((drug doses) OR (drug disease))))) OR (drug dev)) devel ther', tempo de pesquisa: 0.60seg Refinar resultados
In-vitro blood-brain barrier models for drug screening and permeation studies: an overview
MC-PPEA as a new and more potent inhibitor of CLP-induced sepsis and pulmonary inflammation than FK866

Efficacy and safety of a fixed-dose combination of nimesulide/pantoprazole compared to naproxen/esomeprazole for pain relief in patients with osteoarticular diseases and dyspeptic symptoms
Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date

Efficacy of the small molecule inhibitor of Lipid II BAS00127538 against Acinetobacter baumannii
Effect of renal impairment on the pharmacokinetics of prucalopride: a single- dose open-label Phase I study

Current and emerging drugs for the treatment of inflammatory bowel disease
Development and Evaluation of a Physiologically Based Pharmacokinetic Drug-Disease Model of Propranolol for Suggesting Model Informed Dosing in Liver Cirrhosis Patients

Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians
The role of taxanes in triple-negative breast cancer: literature review

Hologram quantitative structure–activity relationship and comparative molecular field analysis studies within a series of tricyclic phthalimide HIV-1 integrase inhibitors
Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art

Antibiotic-modifying activity of riachin, a non-cyanogenic cyanoglycoside extracted from Bauhinia pentandra
Quantification of imatinib in human serum: validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays

Multicomponent nanoparticles as nonviral vectors for the treatment of Fabry disease by gene therapy
Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer

No Relevant Pharmacokinetic Drug–Drug Interaction Between the Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin and Lobeglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in Healthy Subjects
Bioequivalence of a biosimilar enoxaparin sodium to Clexane(®) after single 100 mg subcutaneous dose: results of a randomized, double-blind, crossover study in healthy volunteers

S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis
Changing the face of hepatitis C management – the design and development of sofosbuvir

Ferramentas de pesquisa: Obter Feed RSS — Enviar pesquisa por email — Guardar a pesquisa